The Language Phenotype of Children and Adolescents With Noonan Syndromeстатья из журнала
Аннотация: Purpose This study presents an analysis of language skills in individuals with Noonan syndrome (NS), an autosomal dominant genetic disorder. We investigated whether the language impairments affecting some individuals arise from deficits specifically within the linguistic system or whether they are associated with cognitive, perceptual, and motor factors. Comparisons of language abilities among the different NS genotypes were also conducted. Method Sixty-six children and adolescents with NS were evaluated using standardized speech, language, and literacy assessments. Additional cognitive, perceptual, and motor tasks were administered to examine the relation of these factors to language development. Genotype was noted for those who underwent genetic testing. Results Language impairments were more frequent in NS than in the general population and were associated with higher risk for reading and spelling difficulties. Language was significantly correlated with nonverbal cognition, hearing ability, articulation, motor dexterity, and phonological memory. Genotype analyses suggest that the higher performance of SOS1- positive than PTPN11- positive individuals on language tasks was largely mediated by differences in cognitive ability. Conclusions Our results indicate that variation in language skill in NS is closely related to cognitive, perceptual, and motor factors. It does not appear that specific aspects of language are selectively affected in this syndrome.
Год издания: 2010
Авторы: Elizabeth I. Pierpont, Susan Ellis Weismer, Amy E. Roberts, Erica Tworog‐Dube, Mary Ella Pierpont, Nancy J. Mendelsohn, Mark S. Seidenberg
Издательство: American Speech–Language–Hearing Association
Источник: Journal of Speech Language and Hearing Research
Ключевые слова: Protein Tyrosine Phosphatases, RNA modifications and cancer, Genetics and Neurodevelopmental Disorders
Другие ссылки: Journal of Speech Language and Hearing Research (HTML)
Europe PMC (PubMed Central) (PDF)
Europe PMC (PubMed Central) (HTML)
PubMed Central (HTML)
PubMed (HTML)
Europe PMC (PubMed Central) (PDF)
Europe PMC (PubMed Central) (HTML)
PubMed Central (HTML)
PubMed (HTML)
Открытый доступ: green
Том: 53
Выпуск: 4
Страницы: 917–932